Effect of N-acetylcysteine Combined with Budesonide / Formoterol on T Cell Group, CRP and PTC in Peripheral Blood of Patients with Chronic Obstructive Disease and Bronchiectasis
Objective: To evaluate the effect of N-acetylcysteine combined with
budesonide / formoterol on peripheral blood T cell group, C-reactive protein and
procalcitonin in patients with chronic obstructive disease and bronchiectasis.
Methods: 38 patients with stable BCO after acute attack were divided into two
groups: the combination group and the conventional group. Both groups were treated
with budesonide / formoterol inhaler, and the combination group was treated with
N-acetylcysteine at the same time for three courses. Lung function, CD4+, CD8+, CRP
and PTC were analyzed before and after treatment. Results: (1) The FEV1 and the levels
of CD4+ / CD8+, CRP and PTC in BCO patients were significantly improved by the
two methods; (2) Compared with the conventional group, the improvement of CD4+
and CD8+ in peripheral blood in the combined group was significant. Conclusion:
Compared with budesonide / formoterol alone, combination of N-acetylcysteine and
budesonide / formoterol can effectively improve the systemic inflammatory response in the stable period of BCO, enhance its immunity and anti infection ability, and have
better clinical effect.